COR: nikisha joyner - 3WAY invoicing ------------------------------------------------------------------------------ firm fixed price BPA call against BPA HHSF223201700022B with the center for drug…
Ended Awarded Last action
- Contract number
- 75F40119F19002
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5 Part of Mckinsey & Company, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $8,943,977
Award facts
- Contract value 100% obligated
- $8,943,976.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $8,943,977 |
About this award
This is a firm fixed price BPA call award under BPA HHSF223201700022B with the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) for services related to the New Drugs Regulatory Program Modernization Program. The prime contractor is McKinsey & Company, Inc. Washington D.C., a management consulting firm that provides advisory services to government and private sector clients. The contract has a potential value of $8,943,976.76 and a completion date of February 8, 2020. The contract is under the General Services Administration's Professional Services Schedule. There is no set-aside designation for this award.
Description
COR: nikisha joyner - 3WAY invoicing ------------------------------------------------------------------------------ firm fixed price BPA call against BPA HHSF223201700022B with the center for drug evaluation and research (cder) for the new drugs regulatory program modernization program. ----------------------------------------------------------- contact information ----------------------------------------------------------- vendor
Quick answers
Who was awarded contract 75F40119F19002?
75F40119F19002 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on March 28, 2019.
How much is contract 75F40119F19002 worth?
The government has obligated $8,943,977 on 75F40119F19002.
Is contract 75F40119F19002 an order under another contract?
Yes. 75F40119F19002 is a BPA call under GS10F0118S-HHSF223201700022B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40119F19002 competed?
The extent of competition for 75F40119F19002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award